October 20th, 2010 - 10:16 GMT US FDA Approves Pradaxa® (dabigatran etexilate) – a breakthrough treatment for stroke risk reduction in non-valvular atrial fibrillation Decision marks first approval of a new oral anticoagulant in the USA in 50 years . Read more
